Direct-to-Consumer (DTC) Weight-Loss Medication Market Size, Share & Trends Analysis Report By Drug Type (Prescription Medications, OTC Medications, Herbal and Natural Supplements), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Online Pharmacies, Drug Stores & Retail Pharmacies, Direct Brand websites) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034 Last Updated: July 24, 2026 | Author: Debashree B | Format: | Report Code: SR7264DR | Pages: 110 Direct-to-Consumer (DTC) Weight-Loss Medication Market Size & Growth Analysis The global direct-to-consumer (DTC) weight-loss medication market size is valued at USD 8.64 billion in 2025 and is estimated to reach USD 35.61 billion by 2034, growing at a CAGR of 17.08% during the forecast period
doi: 10.5653/cerm.2018.45.2.57
The most common side effects have to do with the site of injection becoming very sore and red, but careful administration minimizes this risk
Related Reading Zepbound Side Effects Fridays Zepbound Hims Zepbound Form Health Zepbound Pricing and availability current as of June 2026
and M.S.: Formal analysis
This gives you a Day 1 reference point
